Back to Newsroom

Strand Life Sciences to Highlight Clinical Utility Data for StrandAdvantage at 2015 ASCO Annual Meeting

AURORA, Colo., May 14, 2015 – Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, today announced that data regarding the clinical utility of StrandAdvantage, the company’s pan-cancer genomic profiling service, will be featured online at as part of the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

Click here to read more